Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,074,498
+$256,729 QoQ
Shares Held
210,735
+22.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#595
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2020CallValue
$1,332,522
CallShares
36,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $73,658,587 across 13 Drug Manufacturers - General names. PFE ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,696 | $17,626,824 | |
| 2 | JNJ |
Johnson & Johnson
|
62,029 | $15,753,505 | |
| 3 | ABBV |
AbbVie Inc.
|
55,986 | $14,088,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
45,541 | $5,852,018 | |
| 5 | AMGN |
Amgen Inc
|
14,019 | $5,076,560 | |
| 6 | PFE |
Pfizer Inc
This page
|
210,735 | $5,074,498 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
76,251 | $4,393,582 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
13,992 | $1,767,749 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,074,498 | 210,735 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,817,769 | 171,573 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $4,135,217 | 166,073 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,980,103 | 156,205 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,022,022 | 165,925 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,563,531 | 180,092 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $4,020,090 | 151,530 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $4,848,983 | 167,553 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,683,516 | 167,388 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $4,592,902 | 165,510 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $2,356,231 | 81,842 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,728,890 | 172,713 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $6,057,885 | 165,155 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $7,940,985 | 194,632 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $11,241,594 | 219,391 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $9,693,934 | 221,525 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $11,728,853 | 223,705 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $11,775,500 | 227,458 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $15,069,323 | 255,196 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $11,147,632 | 259,187 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $9,722,644 | 248,280 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,076,339 | 250,520 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $9,237,175 | 250,942 | Shares | Sole | 2021-02-09 | |
| 2020-12-31 | $1,332,522 | 36,200 | Call | Sole | 2021-02-09 | |
| 2020-09-30 | $8,036,080 | 218,967 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $6,258,165 | 191,381 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $5,662,281 | 173,477 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||